Baidu
map

急性胰腺炎中医诊疗专家共识意见(2017)

2017-09-20 中华中医药学会脾胃病分会 中华中医药杂志.2017,32(9):4085-4088.

急性胰腺炎(acute pancreatitis,AP)是指多种病因引起的胰酶激活,继以胰腺局部炎性反应为主要特征,伴或不伴其他器官功能改变的疾病。临床以急性上腹痛、恶心、呕吐、发热和血清淀粉酶增高等为特点,大多数患者病程呈自限性,20%-30%患者临床经过凶险,总体病死率5%-10%。本病具有起病急、病情重、并发症多、病死率高等特点,近年来发病率有增加的趋势,是临床常见的消化系统疾病之一。目前,

中文标题:

急性胰腺炎中医诊疗专家共识意见(2017)

发布日期:

2017-09-20

简要介绍:

急性胰腺炎(acute pancreatitis,AP)是指多种病因引起的胰酶激活,继以胰腺局部炎性反应为主要特征,伴或不伴其他器官功能改变的疾病。临床以急性上腹痛、恶心、呕吐、发热和血清淀粉酶增高等为特点,大多数患者病程呈自限性,20%-30%患者临床经过凶险,总体病死率5%-10%。本病具有起病急、病情重、并发症多、病死率高等特点,近年来发病率有增加的趋势,是临床常见的消化系统疾病之一。目前,中西医结合已成为本病主要的治疗手段,其中中医药发挥着重要作用,如中药灌肠、腹部外敷等中医特色疗法在治疗AP合并麻痹性肠梗阻具有一定优势。另外,中医“治未病思想”在AP的临床防治中也有一定的指导作用。鉴于此,中华中医药学会脾胃病分会于2013年公布了《急性胰腺炎中医诊疗专家共识意见》。近年来,随着AP中医研究的进展,有必要对中医诊疗共识意见进行更新,以满足临床诊治的需要。

 

拓展指南:胰腺炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=急性胰腺炎中医诊疗专家共识意见(2017))] GetToolGuiderByIdResponse(projectId=1, id=7aa5a1c001a985b1, title=急性胰腺炎中医诊疗专家共识意见(2017), enTitle=, guiderFrom=中华中医药杂志.2017,32(9):4085-4088., authorId=null, author=, summary=急性胰腺炎(acute pancreatitis,AP)是指多种病因引起的胰酶激活,继以胰腺局部炎性反应为主要特征,伴或不伴其他器官功能改变的疾病。临床以急性上腹痛、恶心、呕吐、发热和血清淀粉酶增高等为特点,大多数患者病程呈自限性,20%-30%患者临床经过凶险,总体病死率5%-10%。本病具有起病急、病情重、并发症多、病死率高等特点,近年来发病率有增加的趋势,是临床常见的消化系统疾病之一。目前,, cover=, journalId=null, articlesId=null, associationId=645, associationName=中华中医药学会脾胃病分会, associationIntro=中华中医药学会脾胃病分会是由民政部备案并于中国科协登记注册的,隶属于中华中医药学会的二级学会。脾胃病分会现任主任委员是首都医科大学附属北京中医医院张声生教授,名誉主任委员李乾构、周学文、单兆伟教授;学会现有学术顾问26名、副主任委员5名、常委36名、委员95名,急症学组委员24名,人员涉及全国29个省市自治区,是全国从事中医、中西医结合消化病临床、科研与教学等工作的专家学者们学术交流的纽带与平台。, copyright=0, guiderPublishedTime=Wed Sep 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>急性胰腺炎(acute pancreatitis,AP)是指多种病因引起的胰酶激活,继以胰腺局部炎性反应为主要特征,伴或不伴其他器官功能改变的疾病。临床以急性上腹痛、恶心、呕吐、发热和血清淀粉酶增高等为特点,大多数患者病程呈自限性,20%-30%患者临床经过凶险,总体病死率5%-10%。本病具有起病急、病情重、并发症多、病死率高等特点,近年来发病率有增加的趋势,是临床常见的消化系统疾病之一。目前,中西医结合已成为本病主要的治疗手段,其中中医药发挥着重要作用,如中药灌肠、腹部外敷等中医特色疗法在治疗AP合并麻痹性肠梗阻具有一定优势。另外,中医“治未病思想”在AP的临床防治中也有一定的指导作用。鉴于此,中华中医药学会脾胃病分会于2013年公布了《急性胰腺炎中医诊疗专家共识意见》。近年来,随着AP中医研究的进展,有必要对中医诊疗共识意见进行更新,以满足临床诊治的需要。 </P> <P> </P>拓展指南:<strong>与<font color=red>胰腺炎</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=b7b5d1c001a64568" title="2017 JSGE临床实践指南:ERCP后胰腺炎" target=_blank>2017 JSGE临床实践指南:ERCP后胰腺炎</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=b0b191c001a08258" title="2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》" target=_blank>2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=08c751c001a05808" title="2017 UEG循证指南:慢性胰腺炎的诊断和治疗" target=_blank>2017 UEG循证指南:慢性胰腺炎的诊断和治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=223f01c00139e335" title="2014 慢性胰腺炎全胰切除术和自体胰岛移植建议" target=_blank>2014 慢性胰腺炎全胰切除术和自体胰岛移植建议</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=d33db1c0013908cd" title="临床实践指南(2016):急性胰腺炎的处理(中文版)" target=_blank>临床实践指南(2016):急性胰腺炎的处理(中文版)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%83%B0%E8%85%BA%E7%82%8E" target=_blank>有关胰腺炎更多指南</a></ul>, tagList=[TagDto(tagId=1021, tagName=胰腺炎), TagDto(tagId=19, tagName=中医)], categoryList=[CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9309, appHits=441, showAppHits=6, pcHits=6628, showPcHits=2944, likes=122, shares=7, comments=3, approvalStatus=1, publishedTime=Fri Sep 22 23:03:33 CST 2017, publishedTimeString=2017-09-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Sep 22 23:03:33 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:44:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=急性胰腺炎中医诊疗专家共识意见(2017))])
急性胰腺炎中医诊疗专家共识意见(2017)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=894415, encodeId=369d894415ef, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jlVibBybCX9jib7HLNNmou5ExFMhNvNjq7oeIwNU8jg8NWPsVEb9piaVzRkTspM3XicYcA0DQfLcBpNYBdUsRBDFYA/132, createdBy=2bab5231080, createdName=重症医学, createdTime=Sun Oct 25 22:26:44 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261766, encodeId=1a59261e66e8, content=谢谢分享.很重要的一条咨询, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Nov 16 18:43:56 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248923, encodeId=3a6424892358, content=谢谢分享.学习受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Sep 29 23:10:26 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2020-10-25 重症医学

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=894415, encodeId=369d894415ef, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jlVibBybCX9jib7HLNNmou5ExFMhNvNjq7oeIwNU8jg8NWPsVEb9piaVzRkTspM3XicYcA0DQfLcBpNYBdUsRBDFYA/132, createdBy=2bab5231080, createdName=重症医学, createdTime=Sun Oct 25 22:26:44 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261766, encodeId=1a59261e66e8, content=谢谢分享.很重要的一条咨询, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Nov 16 18:43:56 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248923, encodeId=3a6424892358, content=谢谢分享.学习受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Sep 29 23:10:26 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-11-16 孙文杰

    谢谢分享.很重要的一条咨询

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=894415, encodeId=369d894415ef, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jlVibBybCX9jib7HLNNmou5ExFMhNvNjq7oeIwNU8jg8NWPsVEb9piaVzRkTspM3XicYcA0DQfLcBpNYBdUsRBDFYA/132, createdBy=2bab5231080, createdName=重症医学, createdTime=Sun Oct 25 22:26:44 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261766, encodeId=1a59261e66e8, content=谢谢分享.很重要的一条咨询, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Nov 16 18:43:56 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248923, encodeId=3a6424892358, content=谢谢分享.学习受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Sep 29 23:10:26 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-29 虈亣靌

    谢谢分享.学习受益匪浅

    0

Baidu
map
Baidu
map
Baidu
map